NeuroMetrix NURO Stock
NeuroMetrix Price Chart
NeuroMetrix NURO Financial and Trading Overview
| NeuroMetrix stock price | 4.58 USD |
| Previous Close | 1.02 USD |
| Open | 1 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 3100 |
| Day's Range | 0.98 - 1.01 USD |
| 52 Week Range | 0.93 - 4.73 USD |
| Volume | 153.34K USD |
| Avg. Volume | 64.33K USD |
| Market Cap | 7.82M USD |
| Beta (5Y Monthly) | 2.307746 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | March 28, 2007 |
| 1y Target Est | N/A |
NURO Valuation Measures
| Enterprise Value | -11928305 USD |
| Trailing P/E | N/A |
| Forward P/E | 2.4932501 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.0182238 |
| Price/Book (mrq) | 0.3525274 |
| Enterprise Value/Revenue | -1.553 |
| Enterprise Value/EBITDA | 2.191 |
Trading Information
NeuroMetrix Stock Price History
| Beta (5Y Monthly) | 2.307746 |
| 52-Week Change | -69.13% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.73 USD |
| 52 Week Low | 0.93 USD |
| 50-Day Moving Average | 1.17 USD |
| 200-Day Moving Average | 1.76 USD |
NURO Share Statistics
| Avg. Volume (3 month) | 64.33K USD |
| Avg. Daily Volume (10-Days) | 77.74K USD |
| Shares Outstanding | 7.84M |
| Float | 7.67M |
| Short Ratio | 0.17 |
| % Held by Insiders | 1.47% |
| % Held by Institutions | 8.81% |
| Shares Short | 21.55K |
| Short % of Float | 0.27% |
| Short % of Shares Outstanding | 0.27% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -65.53% |
| Operating Margin (ttm) | -71.49% |
| Gross Margin | 67.13% |
| EBITDA Margin | -70.88% |
Management Effectiveness
| Return on Assets (ttm) | -13.76% |
| Return on Equity (ttm) | -21.76% |
Income Statement
| Revenue (ttm) | 7.68M USD |
| Revenue Per Share (ttm) | 1.05 USD |
| Quarterly Revenue Growth (yoy) | -25.10% |
| Gross Profit (ttm) | 5.75M USD |
| EBITDA | -5443109 USD |
| Net Income Avi to Common (ttm) | -5032221 USD |
| Diluted EPS (ttm) | -0.71 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 20.25M USD |
| Total Cash Per Share (mrq) | 2.58 USD |
| Total Debt (mrq) | 328.74K USD |
| Total Debt/Equity (mrq) | 1.49 USD |
| Current Ratio (mrq) | 16.293 |
| Book Value Per Share (mrq) | 2.829 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5670452 USD |
| Levered Free Cash Flow (ttm) | -4122628 USD |
Profile of NeuroMetrix
| Country | United States |
| State | MA |
| City | Woburn |
| Address | 4B Gill Street |
| ZIP | 01801 |
| Phone | 781 890 9989 |
| Website | https://www.neurometrix.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 27 |
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Q&A For NeuroMetrix Stock
What is a current NURO stock price?
NeuroMetrix NURO stock price today per share is 4.58 USD.
How to purchase NeuroMetrix stock?
You can buy NURO shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NeuroMetrix?
The stock symbol or ticker of NeuroMetrix is NURO.
Which industry does the NeuroMetrix company belong to?
The NeuroMetrix industry is Medical Devices.
How many shares does NeuroMetrix have in circulation?
The max supply of NeuroMetrix shares is 2.06M.
What is NeuroMetrix Price to Earnings Ratio (PE Ratio)?
NeuroMetrix PE Ratio is 0.00000000 now.
What was NeuroMetrix earnings per share over the trailing 12 months (TTM)?
NeuroMetrix EPS is 0 USD over the trailing 12 months.
Which sector does the NeuroMetrix company belong to?
The NeuroMetrix sector is Healthcare.
NeuroMetrix NURO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 18737.21 USD — |
-1
|
7.88B USD — | 18599.69 USD — | 18841.52 USD — | — - | 7.88B USD — |
| NASDAQ Capital Market Composite RCMP | 112.43 USD — |
+0.26
|
— — | 109.69 USD — | 112.55 USD — | — - | — — |
| Nasdaq Health Care IXHC | 932.02 USD — |
-0.03
|
— — | 920.46 USD — | 933.54 USD — | — - | — — |
| NASDAQ Composite Total Return XCMP | 22955.12 USD — |
-0.99
|
— — | 22786.65 USD — | 23082.91 USD — | — - | — — |
- {{ link.label }} {{link}}